GL1X · GenesisL1 explorer

Research workbench

Second-site screening of K-RAS in the presence of covalently attached first-site ligands

Analyse Second-site screening of K-RAS in the presence of covalently attached… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4Q03
Type
protein
Length
170 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
GTPase KRAS
EC
3.6.5.2
UniProt
P01116
Ligands
GDP, 2XE, MG
Pockets
2 · best druggability 0.54

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGTPase KRAS (EC 3.6.5.2)protein17038% helix, 24% strandP01116

Ligands and binding sites

  • GDP · Guanosine-5'-diphosphate · ligand · chains A
  • 2XE · 4-bromobenzenethiol · ligand · chains A
  • MG · Magnesium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12000.540.7841GDP, MG
2500.330.78112XE

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 4Q03 · Second-site screening of K-Ras in the presence of covalently attached first-site ligands · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.